FibroBiologics Inc. Business Finance Contracts & Agreements

27 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
FibroBiologics Inc.
DE
2025
FibroBiologics, Inc. $5,000,000 Convertible Promissory Note with YA II PN, Ltd. (December 2024)
Note Agreements
FibroBiologics Inc.
NY
2024
Registration Rights Agreement between FibroBiologics, Inc. and YA II PN, Ltd. dated December 20, 2024
Registration Rights Agreements
FibroBiologics Inc.
2024
FibroBiologics, Inc. $5,000,000 Convertible Promissory Note Agreement with YA II PN, Ltd. (December 2024)
Note Agreements
FibroBiologics Inc.
NY
2024
Standby Equity Purchase Agreement between YA II PN, LTD. and FibroBiologics, Inc. dated December 20, 2024
Equity Distribution Agreements
FibroBiologics Inc.
NY
2024
Side Letter Agreement Terminating Share Purchase Agreement and Warrant – FibroBiologics, Inc. and GEM Entities (December 2024)
Purchase Agreements
FibroBiologics Inc.
2024
Amendment No. 2 to Patent Assignment Agreement between SpinalCyte LLC and FibroBiologics, Inc.
Assignment Agreements
FibroBiologics Inc.
2024
Securities Purchase Agreement between FibroBiologics, Inc. and Purchasers (June 2024)
Purchase Agreements
FibroBiologics Inc.
NY
2024
Common Stock Purchase Warrant Agreement between FibroBiologics, Inc. and Holder
Warrant Agreements
FibroBiologics Inc.
NY
2024
Placement Agency Agreement between FibroBiologics, Inc. and Maxim Group LLC (June 2024)
Equity Distribution Agreements
FibroBiologics Inc.
NY
2024
Warrant Agency Agreement between FibroBiologics, Inc. and VStock Transfer LLC (2024)
Warrant Agreements
FibroBiologics Inc.
NY
2024
Securities Purchase Agreement between FibroBiologics, Inc. and Purchasers (April 2024)
Purchase Agreements
FibroBiologics Inc.
NY
2024
Common Stock Purchase Warrant Agreement between FibroBiologics, Inc. and Holder
Warrant Agreements
FibroBiologics Inc.
NY
2024
FibroBiologics, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
FibroBiologics Inc.
DE
2024
Warrant Agreement to Purchase Common Shares of FibroBiologics LLC by GEM Yield Bahamas Limited
Warrant Agreements
FibroBiologics Inc.
NY
2024
Description of FibroBiologics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
FibroBiologics Inc.
DE
2024
FibroBiologics, Inc. Stock Option Grant Notice and Option Agreement (2022 Stock Plan)
Stock Agreements
FibroBiologics Inc.
2023
Amendment 1 to the Patent Assignment Agreement, effective August 2, 2022
Assignment Agreements
FibroBiologics Inc.
2023
Bridge Note dated April 1, 2021, between SpinalCyte LLC and FibroBiologics, Inc
Note Agreements
FibroBiologics Inc.
2023
Registration Rights Agreement dated November 12, 2021, by and among FibroBiologics, LLC GEM Global Yield LLC SCS and GEM Yield Bahamas Limited
Registration Rights Agreements
FibroBiologics Inc.
2023
Share Purchase Agreement dated as of November 12, 2021, by and among FibroBiologics, LLC GEM Global Yield LLC SCS and GEM Yield Bahamas Limited
Stock Agreements
FibroBiologics Inc.
2023
Patent Assignment Agreement dated May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC
Assignment Agreements
FibroBiologics Inc.
2023
Amendment 1 to the Patent Assignment Agreement, effective August 2, 2022
Assignment Agreements
FibroBiologics Inc.
2023
FibroBiologics, Inc. 2022 Stock Plan
Equity Distribution Agreements
FibroBiologics Inc.
DE
2023
Registration Rights Agreement dated November 12, 2021, by and among FibroBiologics, LLC GEM Global Yield LLC SCS and GEM Yield Bahamas Limited
Registration Rights Agreements
FibroBiologics Inc.
2023
Share Purchase Agreement dated as of November 12, 2021, by and among FibroBiologics, LLC GEM Global Yield LLC SCS and GEM Yield Bahamas Limited
Stock Agreements
FibroBiologics Inc.
2023
Patent Assignment Agreement dated May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC
Assignment Agreements
FibroBiologics Inc.
2023